BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 20447570)

  • 21. T cells in atherogenesis: for better or for worse?
    Robertson AK; Hansson GK
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2421-32. PubMed ID: 16973967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
    Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
    Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall.
    Ketelhuth DF; Hansson GK
    Thromb Haemost; 2011 Nov; 106(5):779-86. PubMed ID: 21979058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advantage of having regulatory T cells requires localized suppression of immune reactions.
    Saeki K; Iwasa Y
    J Theor Biol; 2009 Oct; 260(3):392-401. PubMed ID: 19563814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immune tolerance and control of CNS autoimmunity: from animal models to MS patients].
    Liblau R; Cassan C
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S12-22. PubMed ID: 18087225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
    Galle J
    Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic modulation of cutaneous autoimmunity by regulatory T cells.
    Loser K; Beissert S
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii20-2. PubMed ID: 16987825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.
    Piccirillo CA; d'Hennezel E; Sgouroudis E; Yurchenko E
    Curr Opin Immunol; 2008 Dec; 20(6):655-62. PubMed ID: 18926906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokines in the vascular inflammatory response of atherosclerosis.
    Zernecke A; Weber C
    Cardiovasc Res; 2010 May; 86(2):192-201. PubMed ID: 20007309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal number of regulatory T cells.
    Saeki K; Iwasa Y
    J Theor Biol; 2010 Mar; 263(2):210-8. PubMed ID: 19961861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of regulatory T cells in gastrointestinal inflammatory disease.
    van Driel IR; Ang DK
    J Gastroenterol Hepatol; 2008 Feb; 23(2):171-7. PubMed ID: 18289352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular and oral disease interactions: what is the evidence?
    Ford PJ; Yamazaki K; Seymour GJ
    Prim Dent Care; 2007 Apr; 14(2):59-66. PubMed ID: 17462139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis.
    Little PJ; Chait A; Bobik A
    Pharmacol Ther; 2011 Sep; 131(3):255-68. PubMed ID: 21510977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges.
    Nilsson J; Lichtman A; Tedgui A
    J Intern Med; 2015 Nov; 278(5):507-19. PubMed ID: 25659809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice.
    Hermansson A; Johansson DK; Ketelhuth DF; Andersson J; Zhou X; Hansson GK
    Circulation; 2011 Mar; 123(10):1083-91. PubMed ID: 21357823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-tolerance and autoimmunity in a regulatory T cell model.
    Alexander HK; Wahl LM
    Bull Math Biol; 2011 Jan; 73(1):33-71. PubMed ID: 20195912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity.
    Levings MK; Allan S; d'Hennezel E; Piccirillo CA
    Adv Immunol; 2006; 92():119-55. PubMed ID: 17145303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atherosclerosis: immunopathogenesis and immunotherapy.
    Ohashi R; Mu H; Yao Q; Chen C
    Med Sci Monit; 2004 Nov; 10(11):RA255-60. PubMed ID: 15507866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination strategies in atherosclerosis.
    de Jager SC; Kuiper J
    Thromb Haemost; 2011 Nov; 106(5):796-803. PubMed ID: 22012002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.